Skip to content

Effect of Formula on Growth of Infants From Overweight or Obese Mothers

Effect of Protein Levels and Caloric Density on the Growth of Formula Fed Infants From Overweight or Obese Mothers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00820833
Enrollment
230
Registered
2009-01-12
Start date
2007-10-31
Completion date
2014-12-31
Last updated
2015-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Nutrition

Keywords

infant formula, obesity, growth

Brief summary

The purpose of this study is to determine whether infants, from overweight or obese mothers, fed a formula with proteins and calories different than a standard infant formula have a different growth

Interventions

standard infant formula given from 3 to 12 months of age, as per standard requirement

Test formula with different protein and calorie content than standard formula, given from 3 to 12 months of age. As per standard requirement.

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Months to 12 Months
Healthy volunteers
Yes

Inclusion criteria

* healthy newborn infant * birth weight between 2500g and 4800g * singleton birth * mother's BMI before pregnancy was between 26 and 25 * for the breastfeeding group: mother has elected to exclusively breastfeed her baby from birth to at least 6 months of age * for the formula groups: mother has elected to exclusively formula feed her baby from 3 to 6 months of age * having obtained signed informed consent of legal representative

Exclusion criteria

* body weight smaller than 5th percentile for that gestational age * newborn whose mother has diabetes * newborn whose mother has a drug dependence during pregnancy * newborn currently participating in another trial

Design outcomes

Primary

MeasureTime frame
mean weight gain3 months

Secondary

MeasureTime frame
blood test assessments; body composition, bone density9 months

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026